BioCentury
ARTICLE | Clinical News

Symlin pramlintide: NDA under review

April 7, 2003 7:00 AM UTC

Interim16-week data from a 7-month dose-titration study of Symlin in 296 patients showed the use of a dose-titration protocol reduced nausea and the incidence of severe hypoglycemia during initiation ...